Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease IV: Clinical Manifestations01:20

Inflammatory Bowel Disease IV: Clinical Manifestations

64
Inflammatory bowel disease (IBD) encompasses two major chronic disorders—ulcerative colitis and Crohn’s disease—each characterized by relapsing episodes of gastrointestinal inflammation. Although they share certain clinical features, their patterns of involvement and manifestations differ in ways that aid diagnosis and guide management.Ulcerative ColitisUlcerative colitis is limited to the colon and rectum and involves continuous inflammation of the mucosal layer. The...
64
Inflammatory Bowel Disease II: Ulcerative Colitis01:20

Inflammatory Bowel Disease II: Ulcerative Colitis

61
Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal...
61
Inflammatory Bowel Disease I: Ulcerative Colitis01:27

Inflammatory Bowel Disease I: Ulcerative Colitis

1.5K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.5K
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy01:30

Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy

1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
Inflammatory Bowel Disease I: Introduction01:26

Inflammatory Bowel Disease I: Introduction

79
Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows...
79
Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

721
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
721

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A practical definition of conduction block in IvIg responsive multifocal motor neuropathy.

Journal of neurology, neurosurgery, and psychiatry·2005
Same author

Zero-bias anomaly and kondo-assisted quasiballistic 2D transport.

Physical review letters·2005
Same author

Alteration of blood pressure among the donors in a blood donation camp.

Mymensingh medical journal : MMJ·2005
Same author

Dynamics of lithium ions in calcium bismuthate glasses.

The Journal of chemical physics·2005
Same author

Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with beta-thalassemia.

Bone marrow transplantation·2005
Same author

Radioactivity studies along fracture zones in areas around Galudih, East Singhbhum, Jharkhand, India.

Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine·2005

Related Experiment Video

Updated: May 7, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.2K

Comparing disease activity indices in ulcerative colitis.

A J Walsh1, A Ghosh2, A O Brain3

  • 1Currently at Department of Gastroenterology, St Vincent's Hospital, Sydney, Australia.

Journal of Crohn'S & Colitis
|October 15, 2013
PubMed
Summary

Inter-observer variation in ulcerative colitis (UC) disease activity indices impacts clinical trials. The Seo index showed the best agreement, but all indices can affect patient recruitment and outcomes.

Keywords:
Activity indexClinical trial designEndoscopyMayo Clinic indexUlcerative colitis

More Related Videos

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

31.7K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.0K

Related Experiment Videos

Last Updated: May 7, 2026

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model
09:11

Systematic Scoring Analysis for Intestinal Inflammation in a Murine Dextran Sodium Sulfate-Induced Colitis Model

Published on: February 14, 2021

9.2K
Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System
15:49

Flexible Colonoscopy in Mice to Evaluate the Severity of Colitis and Colorectal Tumors Using a Validated Endoscopic Scoring System

Published on: October 16, 2013

31.7K
Investigating Intestinal Inflammation in DSS-induced Model of IBD
08:43

Investigating Intestinal Inflammation in DSS-induced Model of IBD

Published on: February 1, 2012

67.0K

Area of Science:

  • Gastroenterology
  • Clinical Trial Methodology
  • Inflammatory Bowel Disease Research

Background:

  • Limited comparisons exist for ulcerative colitis (UC) disease activity indices.
  • Understanding inter-observer variation is crucial for clinical trial design and interpretation.

Purpose of the Study:

  • To evaluate and compare three UC disease activity indices: Simple Clinical Colitis Activity (SCCAI), Mayo Clinic, and Seo.
  • To assess the impact of inter-observer variation on clinical trial recruitment and outcomes.
  • To determine the clinical relevance of these indices.

Main Methods:

  • Prospective evaluation of 100 UC patients by four specialists.
  • Videosigmoidoscopy scored by each specialist.
  • Comparison of SCCAI, Mayo Clinic, and Seo indices using Kappa statistics for inter-observer agreement and clinical relevance assessment.

Main Results:

  • Good to very good inter-observer agreement was observed for SCCAI (κ=0.75), Mayo Clinic (κ=0.72), and Seo (κ=0.89) indices.
  • Endoscopic scoring within the Mayo Clinic index exhibited the highest variation (κ=0.38).
  • Inter-observer variation could exclude up to 20% of patients from trial recruitment or remission criteria.

Conclusions:

  • Inter-observer variation in UC activity indices significantly affects clinical trial recruitment and outcome measures.
  • Endoscopic scoring is the most variable component among the evaluated indices.
  • The Seo index demonstrated the highest inter-observer agreement, suggesting potential advantages in consistency.